The researchers concluded that Wegovy was superior to a placebo in lowering the risk of death from cardiovascular disease, stroke, and heart attack
If semaglutide is exposed to extreme temperatures (which is above 86F (30C)), its stability and effectiveness can be harmed, leading to the diminishing of its therapeutic benefits
Semaglutide (Ozempic, Wegovy) is an FDA-approved GLP-1 receptor agonist for type 2 diabetes and chronic weight management, formulated exclusively for subcutaneous injection into fatty tissue beneath the skin
Cellular Targeting: Liposomes can fuse directly with your cells, delivering the "cargo" (the glutathione) directly where it is needed most
Guarino D, Moriconi D, Mari A, Rebelos E, Colligiani D, Baldi S, et al